Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 687.00
-29.00 (-4.05%)
May 15, 2026, 1:30 PM CST
Pell Bio-Med Technology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -424.75 | -423.94 | -389.42 | -398.76 | -230.13 | -188.96 |
Depreciation & Amortization | 54.21 | 47.07 | 46.28 | 45.4 | 30.38 | 29.28 |
Other Amortization | 0.05 | 0.05 | 0.6 | 0.22 | 0.66 | 0.88 |
Loss (Gain) From Sale of Assets | -0.02 | - | 0.14 | 0.13 | - | 0.2 |
Loss (Gain) From Sale of Investments | 0.56 | -5.13 | 0.62 | - | - | - |
Loss (Gain) on Equity Investments | -0 | 0 | -0.11 | -0.11 | 0 | -0.01 |
Stock-Based Compensation | 68.42 | 75.12 | 58.97 | 143.06 | 46.68 | 24.96 |
Provision & Write-off of Bad Debts | - | - | - | - | 0.07 | - |
Other Operating Activities | -39.03 | -29.44 | -6.8 | -2.98 | -1.15 | - |
Change in Accounts Receivable | -3.39 | -1.31 | 3.85 | -1.56 | -1.62 | -3.39 |
Change in Inventory | -6.51 | -0.44 | -2.42 | 0.82 | -0.34 | 7.15 |
Change in Accounts Payable | 4.81 | 1.24 | -2.53 | 1.42 | 2.42 | -5.07 |
Change in Unearned Revenue | - | - | - | - | -0.75 | - |
Change in Other Net Operating Assets | 9.62 | 55.49 | 30.69 | 32.37 | -7.2 | 27.13 |
Operating Cash Flow | -336.05 | -281.29 | -260.12 | -179.99 | -160.98 | -107.84 |
Capital Expenditures | -229.73 | -226.41 | -263.79 | -16.49 | -6.5 | -14.48 |
Sale of Property, Plant & Equipment | 0.06 | - | 1 | 3.49 | - | 0.05 |
Sale (Purchase) of Intangibles | -1.44 | -1.19 | -0.19 | - | -2 | - |
Investment in Securities | 265.89 | -290.31 | 228.72 | -402.15 | -536 | 100 |
Other Investing Activities | 23.92 | 20.78 | -61.25 | -4.49 | -6.46 | -1.67 |
Investing Cash Flow | 58.7 | -497.14 | -95.51 | -419.63 | -550.96 | 83.9 |
Short-Term Debt Issued | - | - | 200 | - | 5 | - |
Total Debt Issued | 0.2 | - | 200 | - | 5 | - |
Short-Term Debt Repaid | - | -100 | - | -5 | - | - |
Long-Term Debt Repaid | - | -27.55 | -25.65 | -25.07 | -10.76 | -10.26 |
Total Debt Repaid | -127.94 | -127.55 | -25.65 | -30.07 | -10.76 | -10.26 |
Net Debt Issued (Repaid) | -127.74 | -127.55 | 174.35 | -30.07 | -5.76 | -10.26 |
Issuance of Common Stock | 1,882 | 572.67 | 331.17 | 625.77 | 759.34 | 5.02 |
Repurchase of Common Stock | - | - | - | -0.8 | - | - |
Other Financing Activities | 212.64 | 212.64 | 109.8 | - | 14.99 | - |
Financing Cash Flow | 1,967 | 657.76 | 615.32 | 594.89 | 768.56 | -5.23 |
Net Cash Flow | 1,690 | -120.67 | 259.69 | -4.73 | 56.62 | -29.17 |
Free Cash Flow | -565.78 | -507.7 | -523.91 | -196.48 | -167.48 | -122.32 |
Free Cash Flow Margin | -2188.87% | -1615.65% | -2668.77% | -1089.53% | -976.14% | -875.12% |
Free Cash Flow Per Share | -9.62 | -8.66 | -9.18 | -4.25 | -4.27 | -3.68 |
Cash Interest Paid | 2.05 | 2.05 | 2.26 | 2.56 | 1.36 | 1.52 |
Cash Income Tax Paid | 0.42 | 0.42 | 1.2 | 0.5 | 0 | - |
Levered Free Cash Flow | -389.13 | -763.73 | -588.73 | -53.62 | -86.4 | - |
Unlevered Free Cash Flow | -388.17 | -762.45 | -587.32 | -52.02 | -85.55 | - |
Change in Working Capital | 4.52 | 54.98 | 29.6 | 33.05 | -7.49 | 25.81 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.